InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-6.4%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Sanford Svai S. Director active across 1 company, notably Rani Therapeutics Holdings, Inc.. Cumulatively, 6 filings have been logged. Activity tracked since 9 September 2021. The latest transaction was filed on 27 March 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
139,000 shares0Class A Common StockSEC:0001415889-23-005596:0
3,355 shares@ US$5.959.3% of flowClass A Common StockSEC:0000899243-23-009587:0
18,362 shares@ US$9.8990.7% of flowClass A Common StockSEC:0001209191-22-049802:0
32,900 shares0Class A Common StockSEC:0001209191-22-021021:0
106,200 shares0Class A Common StockSEC:0001209191-21-055777:0
106,200 shares0Class A Common StockSEC:0001209191-21-055777
6 of 6 declarations
About Sanford Svai S
Sanford Svai S is a declarant linked to Rani Therapeutics Holdings, Inc. on XNAS, where the listed role is CFO. He has 6 filings in total, and across the 6 recent sampled filings, the period runs from 2021-09-13 to 2023-03-29, with 0 EUR in buys and 0 EUR in sells; the modal transaction nature is Attribution.
